Cargando…

Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis

Fetal environment is known to be a major predictive factor of type 2 diabetes and cardiovascular disease. However, associations of fetal environment and cord blood glycoforms are uncertain. In this study, we aimed to determine whether glycosylation status in neonatal cord blood is associated with pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Ryosuke, Tsuchiya, Kenji J., Matsuzaki, Hideo, Takei, Nori, Itoh, Hiroaki, Kanayama, Naohiro, Suda, Takafumi, Watanabe, Hiroshi, Ohashi, Tetsu, Tanaka, Masakazu, Nishimura, Shin-Ichiro, Maekawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998769/
https://www.ncbi.nlm.nih.gov/pubmed/27057853
http://dx.doi.org/10.1097/MD.0000000000003219
_version_ 1782450002703941632
author Sato, Ryosuke
Tsuchiya, Kenji J.
Matsuzaki, Hideo
Takei, Nori
Itoh, Hiroaki
Kanayama, Naohiro
Suda, Takafumi
Watanabe, Hiroshi
Ohashi, Tetsu
Tanaka, Masakazu
Nishimura, Shin-Ichiro
Maekawa, Masato
author_facet Sato, Ryosuke
Tsuchiya, Kenji J.
Matsuzaki, Hideo
Takei, Nori
Itoh, Hiroaki
Kanayama, Naohiro
Suda, Takafumi
Watanabe, Hiroshi
Ohashi, Tetsu
Tanaka, Masakazu
Nishimura, Shin-Ichiro
Maekawa, Masato
author_sort Sato, Ryosuke
collection PubMed
description Fetal environment is known to be a major predictive factor of type 2 diabetes and cardiovascular disease. However, associations of fetal environment and cord blood glycoforms are uncertain. In this study, we aimed to determine whether glycosylation status in neonatal cord blood is associated with perinatal outcomes reflecting a poor fetal environment. Thirty-six low birth weight (LBW) infants and 120 normal birth weight infants were recruited from a longitudinal birth cohort. We conducted a comprehensive cord blood N-glycan analysis using matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Associations of N-glycans with perinatal outcomes, including LBW, small for gestational age, and levels of cord blood leptin and adiponectin, were evaluated using logistic or multiple regression. We also prospectively explored correlations between N-glycans and 6 or 18-month rapid weight gain (>0.67 SD score). A total of 35 N-glycans were detected (m/z value 1362.481–3865.407). Of these, abundance levels of G3414 (m/z value 3414.238) were inversely correlated with LBW and small for gestational age. Abundance levels of G1915 (m/z value 1914.698), G2744 (m/z value 2743.994), G3049 (m/z value 3049.105), and G3719 (m/z value 3719.349) were inversely related to LBW. The total N-glycan abundance levels were strongly positively correlated with levels of leptin and adiponectin in cord blood. In a prospective exploratory analysis, the 5 LBW-related N-glycans (G1915, G2744, G3049, G3414, and G3719) were all inversely associated with 6 or 18-month rapid weight gain. These N-glycans are structurally categorized into 2 different categories: fucosylated bi or tri-antennary N-glycans; and tri or tetra-antennary N-glycans without fucosylation. In conclusion, mass spectrometry-based cord blood glycosylation analysis shows that 5 types of N-glycans are potential predictors of a poor fetal environment.
format Online
Article
Text
id pubmed-4998769
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49987692016-08-29 Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis Sato, Ryosuke Tsuchiya, Kenji J. Matsuzaki, Hideo Takei, Nori Itoh, Hiroaki Kanayama, Naohiro Suda, Takafumi Watanabe, Hiroshi Ohashi, Tetsu Tanaka, Masakazu Nishimura, Shin-Ichiro Maekawa, Masato Medicine (Baltimore) 6200 Fetal environment is known to be a major predictive factor of type 2 diabetes and cardiovascular disease. However, associations of fetal environment and cord blood glycoforms are uncertain. In this study, we aimed to determine whether glycosylation status in neonatal cord blood is associated with perinatal outcomes reflecting a poor fetal environment. Thirty-six low birth weight (LBW) infants and 120 normal birth weight infants were recruited from a longitudinal birth cohort. We conducted a comprehensive cord blood N-glycan analysis using matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Associations of N-glycans with perinatal outcomes, including LBW, small for gestational age, and levels of cord blood leptin and adiponectin, were evaluated using logistic or multiple regression. We also prospectively explored correlations between N-glycans and 6 or 18-month rapid weight gain (>0.67 SD score). A total of 35 N-glycans were detected (m/z value 1362.481–3865.407). Of these, abundance levels of G3414 (m/z value 3414.238) were inversely correlated with LBW and small for gestational age. Abundance levels of G1915 (m/z value 1914.698), G2744 (m/z value 2743.994), G3049 (m/z value 3049.105), and G3719 (m/z value 3719.349) were inversely related to LBW. The total N-glycan abundance levels were strongly positively correlated with levels of leptin and adiponectin in cord blood. In a prospective exploratory analysis, the 5 LBW-related N-glycans (G1915, G2744, G3049, G3414, and G3719) were all inversely associated with 6 or 18-month rapid weight gain. These N-glycans are structurally categorized into 2 different categories: fucosylated bi or tri-antennary N-glycans; and tri or tetra-antennary N-glycans without fucosylation. In conclusion, mass spectrometry-based cord blood glycosylation analysis shows that 5 types of N-glycans are potential predictors of a poor fetal environment. Wolters Kluwer Health 2016-04-08 /pmc/articles/PMC4998769/ /pubmed/27057853 http://dx.doi.org/10.1097/MD.0000000000003219 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 6200
Sato, Ryosuke
Tsuchiya, Kenji J.
Matsuzaki, Hideo
Takei, Nori
Itoh, Hiroaki
Kanayama, Naohiro
Suda, Takafumi
Watanabe, Hiroshi
Ohashi, Tetsu
Tanaka, Masakazu
Nishimura, Shin-Ichiro
Maekawa, Masato
Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title_full Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title_fullStr Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title_full_unstemmed Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title_short Fetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation Analysis
title_sort fetal environment and glycosylation status in neonatal cord blood: a comprehensive mass spectrometry-based glycosylation analysis
topic 6200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998769/
https://www.ncbi.nlm.nih.gov/pubmed/27057853
http://dx.doi.org/10.1097/MD.0000000000003219
work_keys_str_mv AT satoryosuke fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT tsuchiyakenjij fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT matsuzakihideo fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT takeinori fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT itohhiroaki fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT kanayamanaohiro fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT sudatakafumi fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT watanabehiroshi fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT ohashitetsu fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT tanakamasakazu fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT nishimurashinichiro fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis
AT maekawamasato fetalenvironmentandglycosylationstatusinneonatalcordbloodacomprehensivemassspectrometrybasedglycosylationanalysis